Guideline on Mineral and Bone Disorder of Chronic Kidney Disease

Description: The guideline includes detailed evidence-based recommendations for the diagnosis and evaluation of the three components of CKD-MBD: abnormalities of serum markers (calcium, phosphorus, parathyroid hormone and vitamin D), vascular calcification and disorders of the bone, followed by recommendations for treatment. It is aimed at practitioners caring for adults and children with CKD Stages 1-4, on chronic dialysis therapy and kidney transplant recipients. The guideline incorporates the new KDIGO grading system that takes into account the strength of the recommendation together with the quality of the evidence. This provides the clinician with a better understanding of the data that led to the development of the recommendation and therefore the applicability to individual patients.
Kidney Disease - Improving Global Outcomes KDIGO 3.4 mB file